These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 369991)

  • 1. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephropathy in the Wiskott-Aldrich syndrome.
    Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
    Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell mediated immunity in patients with Virchowian hanseniasis before and after treatment with transfer factor.
    Leser PG; Margarido L; Belda W; Sartori SG; Hares WA; Freire CA; Fleury R; Montenegro MR; Leser W; Naspitz CK
    Hansenol Int; 1980 Jun; 5(1):3-27. PubMed ID: 7042563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer factor therapy: evidence for nonspecificity.
    Ballow M; Dupont B; Hansen JA; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 8. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
    Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular immunity in acne vulgaris during transfer factor treatment.
    Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K
    Ann Clin Res; 1985; 17(4):152-5. PubMed ID: 2934019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of the transfer factor].
    Mutz I; Humphrey GB
    Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
    [No Abstract]   [Full Text] [Related]  

  • 12. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
    Guss RB; McCulley JP
    Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
    Mobacken H; Hanson LA; Lindholm L; Ljunggren C
    Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer factor therapy in hyperimmunoglobulinaemia E syndrome.
    Kesarwala HH; Prasad RV; Szep R; Oldman E; Lane S; Papageorgiou PS
    Clin Exp Immunol; 1979 Jun; 36(3):465-72. PubMed ID: 487648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer factor therapy in mycosis fungoides: a double-blind study.
    Thestrup-Pedersen K; Grunnet E; Zachariae H
    Acta Derm Venereol; 1982; 62(1):47-53. PubMed ID: 6175137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
    Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
    Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized trial of transfer factor treatment of human warts.
    Stevens DA; Ferrington RA; Merigan TC; Marinkovich VA
    Clin Exp Immunol; 1975 Sep; 21(3):520-4. PubMed ID: 1106927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfer factor II: results of therapy.
    Spitler LE; Levin AS; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):449-56. PubMed ID: 1096990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.